Harshad P. Patil

560 total citations
27 papers, 449 citations indexed

About

Harshad P. Patil is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Harshad P. Patil has authored 27 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Infectious Diseases. Recurrent topics in Harshad P. Patil's work include Influenza Virus Research Studies (11 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Respiratory viral infections research (6 papers). Harshad P. Patil is often cited by papers focused on Influenza Virus Research Studies (11 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Respiratory viral infections research (6 papers). Harshad P. Patil collaborates with scholars based in India, Netherlands and Belgium. Harshad P. Patil's co-authors include Rita Vanbever, Anke Huckriede, Henderik W. Frijlink, Wouter L.J. Hinrichs, Jan Wilschut, Bernard Učakar, Jacqueline de Vries‐Idema, Tjarko Meijerhof, Vidya A. Arankalle and Akhilesh Chandra Mishra and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Harshad P. Patil

26 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harshad P. Patil India 13 148 115 113 111 109 27 449
Kristin M. Tiemann United States 8 60 0.4× 136 1.2× 63 0.6× 118 1.1× 59 0.5× 10 406
Chandan Thomas United States 7 99 0.7× 219 1.9× 67 0.6× 63 0.6× 162 1.5× 8 519
Emilie Seydoux Switzerland 12 122 0.8× 233 2.0× 57 0.5× 345 3.1× 246 2.3× 15 752
Fabrice Rose Denmark 12 105 0.7× 184 1.6× 50 0.4× 51 0.5× 182 1.7× 18 443
Zhiping Sun China 9 65 0.4× 239 2.1× 94 0.8× 257 2.3× 163 1.5× 14 626
Rikhav P. Gala United States 12 34 0.2× 93 0.8× 73 0.6× 44 0.4× 126 1.2× 17 426
Niels Hagenaars Netherlands 7 40 0.3× 171 1.5× 126 1.1× 57 0.5× 240 2.2× 8 483
M. T. ten Kate Netherlands 12 51 0.3× 183 1.6× 213 1.9× 257 2.3× 47 0.4× 13 607
Ankit Mittal India 12 24 0.2× 101 0.9× 149 1.3× 186 1.7× 86 0.8× 54 552
Ilan Babai Israel 12 49 0.3× 118 1.0× 195 1.7× 60 0.5× 214 2.0× 14 462

Countries citing papers authored by Harshad P. Patil

Since Specialization
Citations

This map shows the geographic impact of Harshad P. Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harshad P. Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harshad P. Patil more than expected).

Fields of papers citing papers by Harshad P. Patil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harshad P. Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harshad P. Patil. The network helps show where Harshad P. Patil may publish in the future.

Co-authorship network of co-authors of Harshad P. Patil

This figure shows the co-authorship network connecting the top 25 collaborators of Harshad P. Patil. A scholar is included among the top collaborators of Harshad P. Patil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harshad P. Patil. Harshad P. Patil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huckriede, Anke, et al.. (2025). Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery. Frontiers in Immunology. 16. 1561297–1561297. 2 indexed citations
3.
4.
Patil, Harshad P., et al.. (2022). Immunoglobulin G Subclass Response After Chikungunya Virus Infection. Viral Immunology. 35(6). 437–442. 2 indexed citations
5.
Patil, Harshad P., et al.. (2022). Evaluation of monophosphoryl lipid A as an adjuvanted for inactivated chikungunya virus. Vaccine. 40(34). 5060–5068. 8 indexed citations
6.
Patil, Harshad P., Shubham Shrivastava, Sonali Palkar, et al.. (2021). Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients. Viral Immunology. 34(3). 201–209. 24 indexed citations
7.
Shrivastava, Shubham, Harshad P. Patil, Sonali Palkar, et al.. (2021). Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad. Virus Genes. 57(3). 245–249. 5 indexed citations
8.
Patil, Harshad P., et al.. (2020). Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India. European Journal of Clinical Microbiology & Infectious Diseases. 39(10). 1925–1932. 9 indexed citations
9.
Rocks, Natacha, et al.. (2019). Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity. International Journal of Pharmaceutics X. 1. 100019–100019. 6 indexed citations
10.
Tonnis, Wouter F., Harshad P. Patil, Anne H. de Boer, et al.. (2019). Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination. Acta Pharmaceutica Sinica B. 9(6). 1231–1240. 17 indexed citations
11.
Patil, Harshad P., Gustavo Bracho, Wouter F. Tonnis, et al.. (2018). Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge. Journal of Controlled Release. 288. 199–211. 41 indexed citations
12.
Patil, Harshad P., et al.. (2017). Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy. International Journal of Pharmaceutics. 524(1-2). 159–167. 21 indexed citations
13.
Luo, Tian, Cristina Loira-Pastoriza, Harshad P. Patil, et al.. (2016). PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma. Journal of Controlled Release. 239. 62–71. 60 indexed citations
14.
Patil, Harshad P., Jacqueline de Vries‐Idema, Tjarko Meijerhof, et al.. (2015). Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. European Journal of Pharmaceutics and Biopharmaceutics. 93. 231–241. 16 indexed citations
15.
16.
Patil, Harshad P.. (2014). Development of adjuvanted influenza vaccines for pulmonary delivery. Data Archiving and Networked Services (DANS). 1 indexed citations
17.
Liu, Heng, Harshad P. Patil, Jacqueline de Vries‐Idema, Jan Wilschut, & Anke Huckriede. (2013). Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies. PLoS ONE. 8(7). e69649–e69649. 18 indexed citations
18.
Patil, Harshad P., Wouter ter Veer, Tjarko Meijerhof, et al.. (2013). Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. Journal of Controlled Release. 174. 51–62. 48 indexed citations
19.
Patil, Harshad P., Wouter ter Veer, Tjarko Meijerhof, et al.. (2013). Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 716–725. 33 indexed citations
20.
Liu, Heng, Harshad P. Patil, Jacqueline de Vries‐Idema, Jan Wilschut, & Anke Huckriede. (2012). Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100. PLoS ONE. 7(12). e52135–e52135. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin M. Tiemann Breakdown of academic impact, for papers by Chandan Thomas Breakdown of academic impact, for papers by Emilie Seydoux Breakdown of academic impact, for papers by Fabrice Rose Breakdown of academic impact, for papers by Zhiping Sun Breakdown of academic impact, for papers by Rikhav P. Gala Breakdown of academic impact, for papers by Niels Hagenaars Breakdown of academic impact, for papers by M. T. ten Kate Breakdown of academic impact, for papers by Ankit Mittal Breakdown of academic impact, for papers by Ilan Babai
Rankless by CCL
2026